Eliminate Tuberculosis in Ethiopia (ETBE) (AID RFI 663 19 00002)
- The Agency for International Development, Ethiopia USAID-Addis Ababa in the health sector is offering a public funding opportunity titled "Eliminate Tuberculosis in Ethiopia (ETBE)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 98.001.
- This funding opportunity was created on Mar 08, 2019.
- Applicants must submit their applications by Apr 08, 2019.
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
Browse more opportunities from the same category: Health
Next opportunity: Restoring Fisheries for Sustainable Livelihoods in Lake Malawi (REFRESH)
Previous opportunity: Specialty Crop Block Grant Program – Farm Bill
Grant Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Applicants also applied for:
Applicants who have applied for this opportunity (AID RFI 663 19 00002) also looked into and applied for these:
|Funding Number||Funding Title|
|CDC RFA DP19 1903||Good Health and Wellness in Indian Country|
|HRSA 19 002||Graduate Psychology Education (GPE) Program|
|HRSA 19 089||Opioid Workforce Expansion Program (OWEP) Paraprofessionals|
|HRSA 19 085||Opioid Workforce Expansion Program (OWEP) Professionals|
|RFA HL 20 003||Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) (UG3/UH3 Clinical Trial Optional)|
|RFA HL 20 004||Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) - Research Coordinating Center (RCC) (U24 Clinical Trial Not Allowed)|
|RFA DE 19 010||Limited Competition: Dental, Oral and Craniofacial Tissue Regeneration Consortium (U24 Clinical Trial Not Allowed)|
|RFA HL 20 010||BLOODSAFE: Research to enhance availability of safe blood for patients with severe anemia and hemorrhagic conditions in low or lower-middle income countries (LLMICs) in Sub-Saharan Africa - Data Coordinating Center (DCC) (U24 Clinical Trial Not Allow|
|RFA HL 20 009||BLOODSAFE: Research to enhance availability of safe blood for patients with severe anemia and hemorrhagic conditions in low or lower-middle income countries (LLMICs) in Sub-Saharan Africa (UG3/UH3 Clinical Trial Optional)|
|72067419RFA00005||Karabo ea Bophelo (KB) Activity in Lesotho|
|PA EAA 19 001||Announcement of Availability of Funds for Embryo Adoption/Donation Services and Public Awareness Grants|
|RFA AI 19 014||Atopic Dermatitis Research Network Leadership Center (UM1) Clinical Trial Required|
|SM 19 011||Transforming Lives Through Supported Employment|
|TI 19 009||National Evaluation of the Technology Transfer Center Program|
|PA 19 226||Behavioral and Social Research to Address Health Disparities in the U.S. (Admin Supp Clinical Trial Optional)|
|RFA HS 19 002||Using Data Analytics to Support Primary Care and Community Interventions to Improve Chronic Disease Prevention and Management and Population Health (R18)|
|7200AA19APS00004||Medicines Quality Assurance Systems Strengthening Program (MQASSP)|
|HRSA 19 079||Oral Health Infrastructure (OHI)|
|CDC RFA CK19 1903||Ecological Surveillance for High-Consequence pathogens in Sierra Leone|
|HRSA 19 094||Rural Maternity and Obstetrics Management Strategies Program|
Grant Application Guides and Resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "AID RFI 663 19 00002", eligibility, application service, and/or application tips? Submit an inquiry below: